Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine

Published:2022-01 Issue:1 Volume:84 Page:94-118
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Gobbi Federico,Buonfrate Dora,Silva Ronaldo,Martini Davide,Bisoffi Zeno,Piubelli Chiara,Riccetti Silvia,Sinigaglia Alessandro,Barzon Luisa

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference8 articles.

1. Waning antibodies in SARS-CoV-2 naïve vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers;Tré-Hardy;J Infect,2021

2. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine;Krammer;N Engl J Med,2021

3. Antibody response to the BNT162b2 mRNA COVID-19 vaccine in subjects with prior SARS-CoV-2 infection;Gobbi;Viruses,2021

4. Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study;Buonfrate;Clin Microbiol Infect,2021

5. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection;Khoury;Nat Med,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection;eBioMedicine;2023-03

2. Systemic COVID-19 Vaccination Enhances the Humoral Immune Response after SARS-CoV-2 Infection: A Population Study from a Hospital in Poland Criteria for COVID-19 Reimmunization Are Needed;Vaccines;2022-02-19

3. Comparison of antibody response to two different mRNA Covid-19 vaccines in patients on hemodialysis;Journal of Nephrology;2022-01

4. Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients;Journal of Infection;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3